IBDEI0NK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10769,0)
 ;;=D05.02^^68^675^96
 ;;^UTILITY(U,$J,358.3,10769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10769,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,10769,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,10769,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,10770,0)
 ;;=D05.01^^68^675^97
 ;;^UTILITY(U,$J,358.3,10770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10770,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,10770,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,10770,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,10771,0)
 ;;=D05.00^^68^675^98
 ;;^UTILITY(U,$J,358.3,10771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10771,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,10771,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,10771,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,10772,0)
 ;;=R59.0^^68^675^59
 ;;^UTILITY(U,$J,358.3,10772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10772,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,10772,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,10772,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,10773,0)
 ;;=C83.59^^68^675^99
 ;;^UTILITY(U,$J,358.3,10773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10773,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,10773,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,10773,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,10774,0)
 ;;=C83.50^^68^675^100
 ;;^UTILITY(U,$J,358.3,10774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10774,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,10774,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,10774,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,10775,0)
 ;;=C43.9^^68^675^102
 ;;^UTILITY(U,$J,358.3,10775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10775,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec Site
 ;;^UTILITY(U,$J,358.3,10775,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,10775,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,10776,0)
 ;;=C31.9^^68^675^103
 ;;^UTILITY(U,$J,358.3,10776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10776,1,3,0)
 ;;=3^Malig Neop Accessory Sinus,Unspec
 ;;^UTILITY(U,$J,358.3,10776,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,10776,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,10777,0)
 ;;=C24.1^^68^675^105
 ;;^UTILITY(U,$J,358.3,10777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10777,1,3,0)
 ;;=3^Malig Neop Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,10777,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,10777,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,10778,0)
 ;;=C21.0^^68^675^106
 ;;^UTILITY(U,$J,358.3,10778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10778,1,3,0)
 ;;=3^Malig Neop Anus,Unspec
 ;;^UTILITY(U,$J,358.3,10778,1,4,0)
 ;;=4^C21.0
 ;;^UTILITY(U,$J,358.3,10778,2)
 ;;=^5000930
 ;;^UTILITY(U,$J,358.3,10779,0)
 ;;=C67.9^^68^675^109
 ;;^UTILITY(U,$J,358.3,10779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10779,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,10779,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,10779,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,10780,0)
 ;;=C71.9^^68^675^113
 ;;^UTILITY(U,$J,358.3,10780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10780,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,10780,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,10780,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,10781,0)
 ;;=C18.9^^68^675^115
 ;;^UTILITY(U,$J,358.3,10781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10781,1,3,0)
 ;;=3^Malig Neop Colon,Unspec
 ;;^UTILITY(U,$J,358.3,10781,1,4,0)
 ;;=4^C18.9
 ;;^UTILITY(U,$J,358.3,10781,2)
 ;;=^5000929
 ;;^UTILITY(U,$J,358.3,10782,0)
 ;;=C49.9^^68^675^116
